NPPA notified regarding the computation of the retail price of One Vial of Ceftriaxone & Tazobactam for Injection: Sterile Ceftriaxone Sodium IP eq. to Ceftriaxone 1000 mg + Sterile Tazobactam Sodium IP eq. to Tazobactam 125 mg and each ampoule contains 10 ml sterile water for injection IP for M/s Prosperity 6 Pharmaceutics. (Manufacturer) & M/s Lupin Life Sciences Ltd. (Marketer)

Mar 20, 2025 | by TeamLease RegTech Legal Research Team

Free Legal updates for the week 00


Industry Specific ComplianceThe National Pharmaceutical Pricing Authority (NPPA) on March 19, 2025, notified regarding the computation of the retail price of One Vial of Ceftriaxone & Tazobactam for Injection: Sterile Ceftriaxone Sodium IP eq. to Ceftriaxone 1000 mg + Sterile Tazobactam Sodium IP eq. to Tazobactam 125 mg and each ampoule contains 10 ml sterile water for injection IP for M/s Prosperity 6 Pharmaceutics. (Manufacturer) & M/s Lupin Life Sciences Ltd. (Marketer).

It states that the price of twin pack containing:- One Vial of Ceftriaxone & Tazobactam for Injection: Sterile Ceftriaxone Sodium IP eq. to Ceftriaxone 1000 mg + Sterile Tazobactam Sodium IP eq. to Tazobactam 125 mg and each ampoule contains 10 ml sterile water for injection IP for M/s Prosperity 6 Pharmaceutics. (Manufacturer) & M/s Lupin Life Sciences Ltd. (Marketer) has been revised to Rs. 194.68/-.

[Notification no: 19(4407)/2025/DP/NPPA/DIV.II]


Bookmark

Related Updates



Alternate Text

Get updates on the go on RegUpdate Mobile App.

NEW  ·  AI ASSISTANT